A therosclerosis is a leading cause of morbidity and mortality in the Western world. The initial hallmark of atherosclerotic lesion development is endothelial dysfunction, and one of the main triggers is luminal flow alteration. 1 As a result, vessel bifurcations and vessel curvatures 2 are predilection sites for the development of lesions because of natural disturbance of laminar flow. Here, molecular changes in the endothelium may indicate whether alterations in perfusion are of pathological relevance. different diagnostic probes recognizing activated endothelial cells, such as targeted phospholipid-based micelles 6 for magnetic resonance imaging and ligand-modified microbubbles 7, 8 for molecular ultrasound imaging. Molecular ultrasound was introduced as an extension of conventional ultrasound imaging, 9 which is capable of quantifying flow velocity and back flow within major arteries, providing anatomic and functional data, but which lacks information at the molecular level. 10 Prominent inflammation biomarkers, such as intercellular adhesion molecule 1, 11 vascular cell adhesion molecule 1, 7, 8, 12 P-selectin, 13 and α v β 3 , 14 have already been evaluated for molecular diagnosis of different stages of atherosclerosis [15] [16] [17] [18] by using targeted radiotracers, 6 liposomes, 19 and microbubbles. 8 However, early detection of active endothelial sites remains challenging for many targets because of their constitutive luminal availability, 11, 20, 21 transient upregulation, 11, 20, 21 target access, 22, 23 or partial solubility. 24 Therefore, consensus toward the clinical translation has not yet been found. 25 Nevertheless, junctional adhesion molecule A (JAM-A) has been recently involved in molecular imaging protocols using targeted ultra-small iron oxide particles nanoparticles and microbubbles. 26 JAM-A proved to be the biological marker most responsive to acute changes in blood flow, 27 being upregulated specifically on endothelial cells at the flow-dependent predilection sites of atherosclerosis, 28 which are responsible for monocyte recruitment and accumulation in the vascular wall. 27 Junctional adhesion molecules are members of an immunoglobulin subclass, which under nonpathological conditions are located in the tight junctions of endothelial and epithelial cells, 29 inaccessible from the lumen. Recent studies have shown redistribution of JAM-A to the luminal surface consequent to inflammatory stimuli and endothelial activation and have uncovered a pivotal role for JAM-A in leukocyte recruitment and transmigration. 30, 31 Furthermore, it was found that the knockout of endothelial JAM-A impairs leukocyte migration and confers atheroprotective effects. 30 JAM-A has an important role in leukocyte recruitment on early atherosclerotic endothelium, 30 by supporting endothelial deposition of CC-chemokine ligand 5 from activated platelets. 31 It also modulates the function of C-X-C-chemokine receptor type 4-bearing hematopoietic stem cells by direct interaction. 32 Both facts support the suggestion of JAM-A as an early atherosclerotic lesion marker.
The aim of our study was to evaluate JAM-A as a target for molecular ultrasound imaging of transient endothelial activation under acute blood flow variations. Therefore, we used JAM-A-targeted poly(n-butyl cyanoacrylate) microbubbles (MB JAM-A ) as a contrast agent for molecular ultrasound imaging in a mouse model of flow-induced endothelial activation followed by atherosclerotic plaque development. We found that MB JAM-A bound specifically to JAM-A on activated endothelium and were able to identify the location of areas with endothelial dysfunction. Furthermore, our data show that not only flow reduction because of vessel obstruction but also flow increase because of compensatory blood flow redistribution in the contralateral carotid induce luminal exposure of JAM-A, both illustrating the high sensitivity of this marker for assessing acute vascular vulnerability and remodeling.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Analysis of the Binding Affinity of MB JAM-A In Vitro
The number of bound microbubbles was determined using fluorescence microscopy ( Figure 1A-1E) , showing that MB JAM-A bound ≈7× more (P<0.0001) to stimulated human aortic endothelial cells than to unstimulated cells ( Figure 1F ) and ≈7× more (P<0.0001) than nontargeted control microbubbles. There was no significant difference between the binding efficiency of control nontargeted microbubbles ( Figure 1F ) and MB JAM-A on unstimulated human aortic endothelial cells, showing the binding specificity of the MB JAM-A . Moreover, the binding specificity of MB JAM-A was confirmed by the competitive binding studies ( Figure 1F ).
Molecular Ultrasound Imaging of JAM-A Expression in Carotid Arteries in the Partial Ligation Model
The specificity of MB JAM-A binding was confirmed 2 weeks after partial ligation by the absence of control nontargeted microbubbles retention and by competitive binding experiments using a 20-fold higher concentration of free anti-JAM-A antibody administered before MB JAM-A injection. Compared with normal binding conditions, blocking JAM-A leads to a reduction of MB JAM-A binding by 94% (P=0.0008).
The longitudinal assessment of JAM-A expression by molecular ultrasound revealed a slightly enhanced binding of MB JAM-A to the luminal side of the partially ligated carotid at 1 week post-ligation, followed by a strong increase after 2 weeks (P=0.0009). Subsequently, MB JAM-A binding decreased to a stable level at 3 (P=0.0002) and 4 (P=0.0016) weeks postligation ( Figure 2A ). Interestingly, JAM-A upregulation was also detected in the contralateral carotid 2 weeks after partial ligation (P=0.028), followed by a significant decrease in MB JAM-A binding at the 3 weeks time point (P=0.02) and a normalization 4 weeks post-intervention ( Figure 2B ). In shamoperated mice at 2 weeks post-intervention, the ultrasound signal generated by MB JAM-A was comparable to the mice before partial ligation, which indicates that the opening of the skin and the mobilization of the artery did not induce JAM-A translocation to the luminal surface of the endothelium.
Immunofluorescence of Carotid Arteries in the Partial Ligation Model
To determine the expression pattern and localization of JAM-A during endothelial activation and plaque development, JAM-A and platelet endothelial cell adhesion molecule 1 were stained at 1, 2, 3 and 4 weeks post-surgery ( Figure 2C ). One week after partial ligation of the left carotid artery, only focal areas of endothelia with JAM-A upregulation could be observed compared with sham animals. By week 2, JAM-A expression was strongly increased in both the endothelial and subendothelial layer, reaching a peak in luminal translocation. Despite the lack of ligation (but in line with molecular ultrasound) also in the right carotid artery, an upregulation and luminal exposure of JAM-A were found 2 weeks after ligation of the left carotid artery ( Figure 2D ), which subsequently decreased reaching baseline levels 4 weeks post-surgery.
Morphological and Functional Measures of Arterial Remodeling in the Partial Ligation Model
To investigate the accompanying effects of JAM-A upregulation in both left and right carotid arteries, vascular wall thickness was quantified by ultrasound measurements. The vascular wall thickness in the ligated carotid artery continuously increased over the experimental period with most pronounced changes at the early time points (Figure 3A) , indicating a progressive luminal stenosis ( Figure 3B ). Along with the plaque development and arterial narrowing, a decreased undulation of the vascular wall was observed, as shown by the quantification of lumen variation during systole and diastole ( Figure 3C ).
Interestingly, also in the contralateral carotid, a significant increase (P<0.05) in arterial wall thickness was observed 2 weeks after partial ligation, which, however, did not further progress at later time points ( Figure 3D ). In addition, this increase was not associated with a narrowing of the vessel lumen ( Figure 3E ) or a change in arterial wall undulation during heart activity (data not shown).
Blood flow assessed by Doppler ultrasound was reduced by 56% to 69% over the timespan of 4 weeks in the left carotid artery post-ligation ( Figure 4) . As a compensatory response, the blood flow in the right carotid artery increased reaching a stable value after 3 weeks, suggesting a hemodynamic adjustment of the blood flow after partial ligation.
Inflammatory Serum Markers After Partial Ligation
To determine whether hemodynamic changes induce systemic inflammation and vascular vulnerability, inflammation markers and immune cell content of blood samples were quantified at different time points. The absolute numbers of leukocytes, neutrophils, monocytes, and lymphocytes did not significantly vary during the experiments (Table 1) . Moreover, general inflammatory and anti-inflammatory markers, such as interferon γ, tumor necrosis factor α, granulocyte-macrophage colony-stimulating factor, interleukin-1b, -2, -4, -5, -6, -10, -12, -13, and -17, did not show significant changes in serum of the mice at any time point after partial ligation (Table 2) , indicating the absence of systemic inflammatory condition.
JAM-A and Interleukin-6 Gene Expression in Carotid Arteries After Partial Ligation
Two weeks postpartial ligation, the JAM-A mRNA level in the ligated artery increased (P<0.002) when compared with 
Discussion
In this study, we used JAM-A-targeted poly(n-butyl cyanoacrylate) microbubbles as contrast agents for molecular ultrasound imaging to identify early inflammatory endothelial sites which may develop toward atherosclerotic areas. The luminal availability of JAM-A significantly increased on the endothelium after acute decrease in blood flow in the left carotid artery because of partial ligation. As a result of the flow alteration in the ligated artery and local inflammation, atherosclerotic plaque growth was induced, leading to progressive lumen narrowing. Moreover, atherosclerotic lesion formation was associated with an increase in vascular wall thickness and a decrease in vascular wall undulations during systole and diastole, resembling the characteristics of atherosclerotic vessels in humans. The altered undulation of the artery points to a decreased vascular elasticity resulting from atherosclerotic plaque development and the change in matrix deposition to a high content of elastin. Both the thick cell-rich atherosclerotic plaque with multiple 4',6-diamidino-2-phenylindole-stained layers covering the internal elastic lamina and the increased autofluorescence of the elastic laminas because of the higher content of elastin 33 could be observed in the histological slides.
Decreased perfusion and oscillatory flow 3 represent a major local risk for the development and stability 34 of atherosclerotic lesions, and they also induce a low-level inflammatory state. 35 The onset of plaque growth and endothelial activation was sensitively detected using MB JAM-A 2 weeks after vessel ligation. Although mRNA levels of the systemic inflammatory marker interleukin-6 increased 2 weeks postpartial ligation, no changes were found in the serum over the entire timeframe of the experiment. Therefore, we conclude that the inflammation was locally restricted. Our results are in line with other studies identifying the 2 weeks time period as the biologically active time window in the development of flow-induced endothelial dysfunction toward atherosclerosis. 36, 37 However, the study of Schmitt et al 27 reports an upregulation of junctional JAM-A for an experimental period of 8 weeks. The prolonged upregulation of junctional JAM-A would be interesting to be detected with regular clinical diagnostic modalities and then correlate the results with clinical implications. Although, junctional JAM-A cannot be evaluated by molecular ultrasound using microbubbles because the latter are too big to penetrate into the junctional site of the endothelium. The microbubble size only allows the visualization of biological markers exposed to the luminal side of the endothelial cells. Therefore, this advantage of was recently used by Zhang et al 26 to describe the JAM-A upregulation by the endothelium covering vulnerable atherosclerotic plaques.
Because of the sudden blood flow restriction in the partially ligated left carotid artery, a redistribution of blood flow through the right carotid artery occurs. 38, 39 This leads to GM-CSF indicates granulocyte-macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; n.s., nonsignificant; and TNF, tumor necrosis factor. a higher perfusion in this vessel, which is accompanied by an increased pressure and shear stress. Although we did not observe a dilatation of the lumen in the right carotid artery, we found a compensatory thickening of the arterial wall as an adaptation mechanism to the increased pressure. It has already been described by Caro et al 40 that high wall shear stress has an atheroprotective role but that a sudden change in flow determining the oscillatory shear stress 41 after partial ligation is the promotor of atherosclerosis. This explains our findings in the contralateral carotid artery, where an acute increase in blood flow from normal state to a high state induces a transitory endothelial dysfunction which was faithfully detected with MB JAM-A (2 weeks postpartial ligation) until the adaptation mechanisms was completed (3 weeks postpartial ligation). This hypothesis is further supported by the lack of elevated systemic inflammatory markers in the serum that would suggest a systemic inflammatory reaction. Thus, we postulate that endothelial cells are able to react toward temporal shear stress fluctuations 35, 42 but also to adapt when the blood flow stabilizes. 42 In this context, JAM-A expression and imaging faithfully depict the biochemical changes taking place at the endothelial level, highlighting the potential of JAM-A as a versatile biochemical marker for endothelial activation. By using JAM-A as a biomarker to assess early stages of atherosclerotic plaque formation, molecular ultrasound using MB JAM-A may enable the delineation of predisposed areas of atherosclerotic plaque development and the alternation in the onset and remission of atherosclerosis. The advantage of molecular ultrasound is that echography is a radiation-free, real-time, cheap, and broadly available diagnostic imaging modality. The imaging protocol could be applied to patients with cardiovascular disease who experience repeated paroxysmic high blood pressure episodes to detect acute activation of atherosclerosis-prone sites, and to adapt the medication accordingly, to thereby overcome worsening episodes of the cardiovascular disease.
Despite these promising results, there is still optimization required for the molecular ultrasound method. On the one hand, because of the short circulation time and high flow conditions, the unspecific binding of the microbubbles to the glycocalyx or their internalization by macrophages is low. 43 On the other hand, short circulation times limit the time span during which microbubbles can bind to their target. In addition, because of the physiological high flow conditions in the arteries, the retention of microbubbles at the target is relatively short, which can make it difficult to investigate larger vessel areas by ultrasound. However, compared with our study in mice, a clinical setup would benefit from the larger vessel diameters, the higher vessel surface area, and the slower arterial flow. In addition, by using smaller targeting moieties and by increasing the number of targeting ligands on the microbubble surface, for example, by microbubble shell functionalization with dendrimeric spacers, 44 the target affinity and binding strength of microbubbles could be improved.
Although the applicability of ultrasound is limited to segmental body imaging, other imaging modalities, such as positron emission tomography, single-photon emission computed tomography, and magnetic resonance imaging, could be applied for whole body screening for predilection sites of atherosclerosis. In this context, JAM-A-targeted probes for positron emission tomography, single-photon emission computed tomography, and magnetic resonance imaging could be easily generated using the same binding moiety, thus highlighting the broad scope of the presented molecular imaging approach.
In conclusion, we demonstrate that noninvasive molecular ultrasound with MB JAM-A is capable of detecting focal areas of transient endothelial activation triggered by the oscillatory blood flow condition. Thus, molecular ultrasound with MB JAM-A may have the capacity to indicate predisposed areas of atherosclerotic plaque development, the onset of atherosclerosis, and its normalization during therapy. and the IL-6 (B) levels were increased in the ligated carotid arteries 2 wk postligature. In the contralateral carotid, no significant increase of mRNA levels was identified. Statistical significance was calculated using the 1-way ANOVA followed by the Newman-Keuls post hoc-test. Error bars represent the SDs.
